Fora Capital, LLC Fibrogen Inc Transaction History

Fora Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$15.95 - $25.18 $164,683 - $259,983	10,325 New	10,325 $192,000
Q2 2021 Aug 16, 2021	SELL	$18.57 - $35.68 $44,753 - $85,988	-2,410 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$31.0 - $55.72 $74,710 - $134,285	2,410 New	2,410 $84 Million
Q3 2020 Nov 13, 2020	SELL	$40.47 - $45.5 $269,651 - $303,166	-6,663 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$32.57 - $42.83 $217,013 - $285,376	6,663 New	6,663 $270 Million
Q1 2020 May 15, 2020	SELL	$23.3 - $45.96 $206,904 - $408,124	-8,880 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$34.58 - $48.06 $307,070 - $426,772	8,880 New	8,880 $380,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.